Patient Eligibility for Utilizing Anti-CTLA4-Containing Regimens
A conversation on patient tolerance of CTLA-4 immunotherapies, alongside an exploration of treatment-related adverse reactions is discussed by a panel of experts.
Mark Socinski Martin Dietrich Pd L1 Negative Resistance Mutations Ctla 4 Combination Immunotherapies
Source: ajmc.com